BioNTech’s (BNTX) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of BioNTech (NASDAQ:BNTX – Free Report) in a research report released on Thursday morning,Benzinga reports. They currently have a $134.00 target price on the stock. BNTX has been the subject of a number of other research reports. Citigroup reissued a “buy” rating and issued a $140.00 target […]
HC Wainwright reiterated their buy rating on shares of BioNTech (NASDAQ:BNTX – Free Report) in a research report released on Thursday morning,Benzinga reports. They currently have a $134.00 target price on the stock. BNTX has been the subject of a number of other research reports. Citigroup reissued a “buy” rating and issued a $140.00 target […]
-limited-logo-1200x675.png&w=240&h=240&zc=2){kind=logo}
